Dear Trader...
Fund
Houses Recommendations
- CLSA on SBI Life: Maintain
Outperform on Company, raise target price at Rs 2180/Sh (Positive)
- MS on SBI Life: Maintain
Overweight on Company, target price at Rs 2115/Sh (Positive)
- CLSA on REC: Maintain
Outperform on Company, target price at Rs 525/Sh (Positive)
- GS on Syngene: Maintain Buy on
Company, target price at Rs 775/Sh (Positive)
- Bernstein on Coforge: Maintain
Outperform on Company, target price at Rs 2038/Sh (Positive)
- MS on Sun Pharma: Maintain
Overweight on Company, target price at Rs 1960/Sh (Positive)
- Investec on Torrent Pharma:
Upgrade to Buy on Company, raise target price at Rs 4100/Sh (Neutral)
- Macquarie on Nestle: Maintain
Neutral on Company, cut target price at Rs 2250/Sh (Neutral)
- Jefferies on SRF: Maintain
Underperform on Company, raise target price at Rs 2640/Sh (Neutral)
- Jefferies on Supreme Ind:
Maintain Buy on Company, cut target price at Rs 5100/Sh (Neutral)
- Citi on ABAMC: Maintain Sell on
Company, raise target price at Rs 820/Sh (Neutral)
- UBS on CG Power: Maintain Buy on
Company, cut target price at Rs 890/Sh (Neutral)
- Jefferies on Bajaj Fin: Maintain
Buy on Company, raise target price at Rs 1100/Sh (Neutral)
- UBS on Bajaj Fin: Maintain Sell on
Company, target price at Rs 750/Sh (Neutral)
- Macquarie on Bajaj Fin: Maintain
Underperform on Company, target price at Rs 800/Sh (Neutral)
- Bernstein on Bajaj Fin: Maintain
Underperform on Company, cut target price at Rs 640/Sh (Negative)
- JP Morgan on Bajaj Fin: Downgrade
to Neutral on Company, cut target price at Rs 970/Sh (Negative)
Warm Regards...
Join Channel :- https://whatsapp.com/channel/0029VaVkaZX8Pgs7nE7Hk33O
The securities quoted are for illustration only and are not recommendatory. Investment in securities market are subject to market risks. Read and agree Disclaimer and related all the documents carefully before investing, mentioned on www.nikhilbhatt.in
No comments:
Post a Comment